1. The Board of Directors in its meeting held on 29 May 2010 has approved the Annual accounts for the year ended 31 March 2010 subject to the adoption by the members in its Annual General Meeting.
2. The Board has approved CAPAX of
130 crore for capacity enhancement and diversification for more pharmaceuticals product.